About Famy Life Sciences
Famy Life Sciences is a company based in Ahmedabad (India) founded in 2008 was acquired by Viatris in November 2022. The company has 8 employees as of March 27, 2024. Famy Life Sciences offers products and services including Clinical Assets and Therapeutics Portfolio. Famy Life Sciences operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
- Headquarter Ahmedabad, India
- Employees 8 as on 27 Mar, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Famy Life Sciences Private Limited
- Date of Incorporation 27 Oct, 2008
- Jurisdiction Shaikpet, Telangana, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Famy Life Sciences
Famy Life Sciences offers a comprehensive portfolio of products and services, including Clinical Assets and Therapeutics Portfolio.
Developing innovative molecules for unmet needs in ophthalmology and other areas.
Building and advancing assets for oncology, dermatology, and related fields.
Funding Insights of Famy Life Sciences
Detailed funding history for Famy Life Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Famy Life Sciences
Famy Life Sciences has secured backing from 1 investor. Prominent investors backing the company include Viatris.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Branded pharmaceuticals are developed and commercialized by Viatris internationally.
|
Locked | Locked | Locked |
Investor details for Famy Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Famy Life Sciences
Investment portfolio details for Famy Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Famy Life Sciences
Detailed financials for Famy Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Famy Life Sciences Comparisons
Peer comparison for Famy Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Famy Life Sciences
Famy Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| Locked | Locked | Locked |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
APIs and finished dosage forms are developed and manufactured.
|
Detailed competitors of Famy Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Famy Life Sciences
Complete news archive for Famy Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Famy Life Sciences
Famy Life Sciences was founded in 2008.
Famy Life Sciences is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
As of Mar 27, 2024, the latest employee count at Famy Life Sciences is 8.
Annual revenue of Famy Life Sciences is $13.1M as on Mar 31, 2022.
Famy Life Sciences was founded in 2008 and is headquartered in Ahmedabad, India. Drug development services are provided across therapeutic areas including ophthalmology, oncology, dermatology, and others. Operations focus on clinical research and support for pharmaceutical clients, with expertise in regulatory compliance and trial management. The company is led by key executives in a competitive contract research sector.
Famy Life Sciences's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
Famy Life Sciences offers Clinical Assets and Therapeutics Portfolio.
Famy Life Sciences has 1 investor. Key investors include Viatris.